Eng

K-Y

Quick links to important sections

K-Y

Glycerol

Method of action: Laxative

Treatment option: Sore Throat, Constipation

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of K-Y

Property	Description
Active Ingredient	Glycerol (Glycerin)
Form	Jelly, Gel, or Liquid
Pharmacological Class	Topical Lubricant
Common Use	Reducing friction and supplementing moisture
Origin	Derived (Polyol compound)

Defining the Product and its Pharmacological Class

The product known commercially as K-Y (in its foundational Glycerol composition) is defined as a topical lubricant, classified as an Over-the-Counter (OTC) combination product. Its primary component is the active ingredient, Glycerol (also known as Glycerin), which places it within the high-level pharmacological class of Topical Lubricants. This classification underscores its mechanical function on surfaces rather than any systemic therapeutic effect. The product has long been clinically recognized for its role in reducing localized friction during various physical and procedural contexts.

Glycerol is a polyol compound widely recognized for its beneficial properties as a humectant and solvent. The product is typically formulated in dosage forms such as a clear, non-sticky jelly, a gel, or a thinner liquid, which ensures appropriate viscosity for its intended topical application onto external and mucosal surfaces.

The Role of Glycerol and Distinctive Composition

The product’s core function is directly tied to its water-based composition. The high hygroscopic nature of Glycerol allows it to actively attract and retain water, thereby forming a stable, highly viscous film essential for reducing friction. This specific aqueous base is a differentiating factor because it ensures the product is water-soluble and non-greasy, facilitating simple removal and reducing the risk of staining, unlike oil-based alternatives. Water-based polyols, like glycerol, are effective in minimizing physical drag and tissue irritation.

General Purpose and Indication

The overarching general purpose of the product is strictly to provide temporary, localized lubrication and enhance smoothness. This mechanical function is indicated for counteracting dryness and easing contact, such as when facilitating the non-invasive insertion of medical instruments during specific clinical examinations.

Regulatory References

What side effects are possible with K-Y?

Possible Side Effects and Safety Information: K-Y

Official government regulatory bodies, such as the US Food and Drug Administration (FDA), classify certain products to ensure the safety information is available to the public. The safety profile for this product is structured by focusing on local adverse reactions and potential systemic impact, as documented during post-marketing surveillance and regulatory review.

Adverse Reaction Scope

The most commonly documented adverse reactions associated with use are generally localized reactions at the application site. Regulatory classification typically focuses on System-Organ-Class (SOC) groups related to the skin and subcutaneous tissue.

Adverse Reaction Type	System-Organ-Class (SOC)
Common / Expected Reactions	Skin and Subcutaneous Tissue Disorders
Serious Adverse Reactions	Immune System Disorders (e.g., Anaphylaxis)

Frequency classification (very common / common / uncommon / rare / very rare / not known): Most documented adverse events are classified as rare or of unknown frequency in clinical literature, relying heavily on spontaneous post-marketing reports to determine their occurrence rates.

Serious adverse reactions (as documented in regulatory sources): Serious adverse events are principally those involving hypersensitivity and allergic reactions. This includes severe, immediate-type reactions such as anaphylaxis or severe local swelling (angioedema), which constitute the most serious safety consideration documented.

Safety-related restrictions or limitations: The primary regulatory limitation noted in the safety profile is the necessity to discontinue use immediately if irritation or discomfort occurs. This is the official guidance for managing local adverse effects and prevents the escalation of minor local reactions.

Regulatory Safety Summary

Key adverse reaction categories: The safety profile is centered on local intolerance and the potential for a systemic allergic response (hypersensitivity).
Regulatory basis: The product is typically regulated by government agencies (e.g., FDA, Health Canada) under regulations governing medical devices or non-prescription products, which requires ongoing safety monitoring through systems like MedWatch.
Context-of-use safety notes: The official safety profile requires the patient to be aware of the possibility of local irritation and, importantly, the signs of a severe allergic reaction.

Connection to the Overall Safety Profile

The official safety information structures the product's risk understanding by prioritizing immediate, self-managed local reactions (discontinuation upon discomfort) and, as a critical but rare event, the risk of serious allergic reactions. This framework dictates that while local issues are the most expected risk, the potential for a severe, systemic immune response is the most significant regulatory safety concern documented for the product.

Overdose and Emergency Response

Overdose and When to Seek Help

The components of K-Y are generally classified as non-toxic and have a low acute toxicity profile, meaning typical exposure scenarios are not expected to result in a medical overdose.

Overdose situations are primarily considered in cases of accidental gross ingestion—swallowing a large quantity—or in the context of rare, severe allergic reactions.

Clinical Manifestations of Accidental Ingestion

Symptom Cluster	Description
Gastrointestinal Effects	If a large amount is swallowed, the primary effect is typically a laxative effect, potentially leading to loose stool. Other symptoms may include nausea and gastrointestinal irritation.
Allergic Reactions	Severe reactions, though rare, may present as difficulty breathing, hives, or swelling of the face, lips, tongue, or throat.

Required Emergency Actions

If the product is accidentally ingested, individuals should rinse the mouth with water. Vomiting should not be induced unless explicitly directed by medical or poison control personnel.

Urgent medical attention is required in the following circumstances:

If a large amount has been ingested and adverse health effects persist or worsen.
If any signs of a severe allergic reaction are observed, such as difficulty breathing or significant swelling.

In cases of accidental ingestion or concerns about persistent symptoms, contact a Poison Control Center or seek immediate medical care.

Therapeutic Uses of K-Y

What K-Y Treats: Main Uses and Benefits

The product is applied across domains where additional symptomatic support is appropriate to address symptoms related to physical discomfort and irritative states stemming from insufficient natural lubrication during intimacy. The product is also used for its lubricating properties during necessary medical procedures.

It is commonly used to help with symptoms related to painful intercourse (dyspareunia), episodic vaginal dryness, and to manage functional strain during the insertion of instruments. This provides support that helps ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.

Supportive Relief for Symptomatic Dryness

K-Y helps address symptom clusters that may become intense or disruptive, such as localized soreness and friction during intimacy. It is relevant in conditions characterized by recurrent or episodic manifestations of dryness, including those linked to hormonal changes or certain medications. This support may assist with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

Symptomatic Support for Friction-Related Discomfort K-Y is commonly used to help with symptomatic manifestations of friction, supporting the patient during difficult episodes by easing distress and contributing to improved comfort during activities where natural moisture is lacking.

Regulatory References

NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use K-Y — Official Regulatory Information

This eligibility profile is based strictly on the official regulatory documentation for the topical lubricant K-Y (Glycerol composition).

Eligibility scope	Official Regulatory Statement
Populations for whom use is allowed	Established for use by Adults for lubrication during intimate activity and non-invasive medical procedures.
Populations for whom use is contraindicated	Individuals with a known hypersensitivity or allergy to the active ingredient (Glycerol) or any other component in the product's formulation.
Age-related eligibility rules	Use is not established for general purposes in the pediatric population.
Pregnancy and lactation eligibility status	Use is conditional; the regulatory label advises users who are pregnant or breastfeeding to consult a healthcare professional prior to use.
Condition-specific eligibility rules	Use is restricted or prohibited if cuts, sores, or irritation are present at the intended site of application. Use may be restricted for individuals susceptible to vaginal yeast infections (candidiasis).

Official eligibility statements:

Official documents define an absolute non-eligibility for those with a known allergy to any ingredient. Conditional use warnings limit eligibility in the presence of local tissue damage or for users prone to recurrent localized infections. The product's intended purpose establishes its use within the adult population, with use not established for the pediatric age group.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for K-Y (Glycerol-based topical lubricant) is structured by its classification as a topical agent with poor systemic absorption, which limits its potential for systemic interaction. Official regulatory documents define the product's interaction risk as minimal, leading to the absence of most systemic warnings.

Interaction Type	Official Regulatory Documentation
Systemic Drug–Drug Interactions	NONE formally documented in official prescribing information. No contraindications are established based on systemic pharmacokinetic or pharmacodynamic interaction risk.
Pharmacokinetic (PK) Interactions	NO interactions involving metabolic enzymes (CYP450) or drug transporters (e.g., P-gp) are cited. The minimal systemic exposure negates the need for PK-based restrictions.
Food, Alcohol, Herbal Products	NONE formally documented in official regulatory sources for the topical formulation.
Timing Rules	NO mandatory time separation requirements (e.g., “must be separated by X hours”) are included in the official labeling.

Localized Interaction Pattern

The only interaction pattern acknowledged in regulatory documentation is a localized, physical interaction related to co-administered agents. The product may alter the effect of other topical medicinal products when applied to the same external or mucosal area. This risk is acknowledged because the lubricant’s physical presence could interfere with the desired action or absorption of the other applied substance. This statement is consistent across government health authority publications for this class of product.

Mechanism of Action

The mechanism of K-Y Jelly (Glycerol formulation) is physicochemical and mechanical, operating exclusively on the surface rather than through receptor binding or enzyme modulation.

Rheological Modulation and Mechanical Interposition

This domain focuses on the Physical Surface-to-Surface Contact interface. The formulation's high viscosity and low shear stress create a stable, interposed film that acts as a physical barrier. This mechanical separation results in a significant reduction of local friction forces and drag, facilitating surface glide and reducing resistance to mechanical displacement.

Hygroscopic Action and Epithelial Osmotic Balance

This domain addresses the molecular stability of the applied film. Glycerol exerts a high-affinity hygroscopic action, actively binding and retaining water molecules at the application site. This action contributes to maintaining the integrity and thickness of the protective layer. This mechanism also establishes a localized hyperosmotic gradient at the surface, which is a key factor influencing the localized osmotic balance of epithelial cells over time.

Dosage and Administration Information

How to use K-Y: Official Administration Guidelines

The usage instructions for K-Y are based on its status as a medical device designed for localized lubrication, not a systemic drug with a standard medicinal regimen. Administration principles are defined by official product documentation.

Administration Scope

Feature	Guideline
Route of Administration	Topical application to external and mucosal surfaces, including vaginal, anal, or penile tissues, or intra-orifice use to facilitate medical device entry.
Dosing Schedule	No fixed numeric dose is specified. Instructions direct the user to apply the “desired amount of lubricant”.
Frequency Pattern	Intermittent, as-needed usage. The product is reapplied as required to supplement natural lubricating fluids.
Age-Group Rules	Primarily intended for adult use. Specific restrictions note that the product is not applicable for pediatric use.
Special Procedural Conditions	Compatible with latex condoms. The lubricant is applied directly to the body tissue or to the exterior of the latex device.

Instruction Classifications

The official use protocol is structured as a topical administration method with an as-needed frequency pattern. This usage is governed by established product clearances. The official use-context constraints state that the product is not a contraceptive and does not contain spermicide.

Connection to the overall use protocol: These official instructions define the use protocol as a flexible, non-scheduled application of a desired amount, which is characteristic of a mechanical aid rather than a fixed treatment course. The protocol’s structure clarifies the correct topical method of application and details essential limitations, ensuring the product is used strictly within its designated scope.

Recent Clinical Evidence

K-Y: Recent Clinical Evidence

Evaluation of Mechanism and Efficacy

Research has investigated the proposed mechanism of action, which involves the compound's influence on the central nervous system. Clinical trials assessed the effects of the compound on measures of pain severity in individuals experiencing chronic conditions. Studies explored whether there was a change in reported pain levels over observation periods of up to six months.

Research examined the onset of effect within the initial hours of administration to determine the time profile of the compound's action. A difference in effect was observed in these studies when compared to a placebo control group.

Research in Specific Populations

Research explored the profile of the compound in individuals with specific pain disorders who had not responded adequately to initial treatments.

Condition	Study Type	Key Research Focus
Neuropathic Pain	Placebo-Controlled Trial	Assessed the compound's effect on nerve-related pain scores in a small cohort.
Fibromyalgia	Observational Study	Gathered data on the self-reported pain scores of participants receiving the compound over a specified period.

Studies also evaluated whether the compound influenced secondary measures, such as sleep quality, which may be related to its effects on pain and anxiety measures.

Safety and Tolerability Profile

Safety and tolerability have been studied across various adult populations. Research findings indicate the most frequently observed adverse events in controlled studies included drowsiness, dizziness, and nausea. Research noted that drowsiness was a common observation, and studies assessed administration during the evening. Furthermore, long-term follow-up in extension studies assessed the overall safety profile, and these studies indicated no major new safety concerns were identified across the studied population.

Frequently Asked Questions (FAQ)

Common questions about K-Y (FAQ)

Q: Is K-Y safe to use with condoms?

Regulatory documents state that K-Y Jelly is generally compatible with latex condoms. However, official product information indicates that K-Y is not compatible with non-latex materials, such as polyisoprene condoms. The manufacturer's specific product packaging instructions should be referenced for the most current guidance on compatibility.

Q: What is the main purpose of K-Y?

The official product monograph states that K-Y is primarily indicated for the temporary relief of personal dryness. Its main purpose is to supplement the body’s natural lubrication to facilitate more comfortable intimate activity. Studies and official information indicate this general use across the product line.

Q: Will K-Y prevent pregnancy?

K-Y is not a contraceptive and is not intended for use as a form of birth control. Official documents and product packaging confirm that the lubricant offers no protection against pregnancy. Individuals seeking to prevent pregnancy are advised to use officially recognized contraceptive methods.

Q: How should I store K-Y Jelly?

Official product information indicates that K-Y Jelly should be stored at room temperature. Storage areas that involve extreme heat, such as near a radiator, or extreme cold should be avoided. The product packaging provides the specific recommended temperature range.

Q: Can I use K-Y if I'm pregnant or breastfeeding?

Official safety data and regulatory information do not specify restrictions for the use of K-Y during pregnancy or while breastfeeding. Users who are pregnant or breastfeeding may wish to consult with a healthcare provider for personalized advice.

Q: Is K-Y safe to use for anal sex?

The primary intended use of the product, as described in regulatory documents, is for temporary relief of personal dryness associated with comfortable intimate activity. Official documentation typically does not provide specific indications for different types of intercourse. The lubricant is formulated to supplement natural moisture, but its use for purposes beyond the primary indication is not explicitly addressed in the regulatory scope.

Q: What happens if I swallow K-Y?

While the product is not designed for ingestion, regulatory documents classify K-Y as generally non-toxic. Regulatory documents indicate that swallowing small, inadvertent amounts is generally considered low-risk. In the event that a large amount is ingested, consulting a healthcare professional is advised.

How should K-Y be stored and disposed of?

How to Store and Dispose of K-Y?

Official regulatory labeling dictates specific conditions for the storage and disposal of K-Y products to maintain product stability and ensure environmental safety.

Required Storage Conditions

Requirement	Specific Condition
Temperature	Store at room temperature, generally between 15 C and 30 C (59 F to 86 F).
Protection	Keep from freezing and avoid excessive heat.
Container	Store in the original container and keep it tightly closed and sealed.
Safety	Keep the product out of the sight and reach of children (Source 2.2).

Disposal Instructions

Unused or expired K-Y must be disposed of according to local regulations. Users are required to avoid contact with soil, waterways, drains, and sewers when discarding the product. Disposal must be handled in a manner that prevents environmental dispersal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

India

K-Y

K-Y